Tradestie Institutional Equity Comparison Engine
TWST vs RAPT โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
RAPT Overall Edge
RAPT Captures Institutional Edge (3โ0 Pillars ยท 5โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to RAPT Therapeutics, Inc. Common Stock (RAPT) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, TWST trades at N/M Forward P/E with -31.9% operating margin (+23.2% YoY revenue) versus RAPT at N/M Forward P/E and 0.0% operating margin (-100.0% YoY). In options structure, TWST sits in CONSOLIDATION (18th %ile IV; Dealer Gamma Walls on Pro) against RAPT sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
TWST N/M vs RAPT N/M Fwd P/E
Growth & Margin Winner
RAPT
Op Margin -31.9% vs 0.0% ยท YoY +23.2% vs -100.0%
Momentum & Technical Winner
RAPT
1Y +253.2% vs +480.2% ยท 52W Pos 42% vs 100%
Options & Structure Winner
RAPT
CONSOLIDATION (18th %ile IV) vs UNCLASSIFIED (<1st %ile IV)
TWST
NASDAQ
Twist Bioscience Corporation Common Stock
Biological Products, (No Disgnostic Substances)
$105.61
-5.37% 1D
Market Cap
$7.6B
1M Return
-20.44%
1Y Return
+253.21%
Forward P/E
N/M
Unified AI Score
51.7 / 100
HOLD
Tech 40.0
Fund 56.0
Flow 68.0
Mom 64.0
RAPT
NASDAQ
RAPT Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$58.02
+0.07% 1D
Market Cap
$1.7B
1M Return
+0.68%
1Y Return
+480.2%
Forward P/E
N/M
Unified AI Score
52.4 / 100
HOLD
Tech 40.0
Fund 46.0
Flow 61.0
Mom 40.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
TWST +253.21%
RAPT +480.2%
Spread: +31.16 pp (RAPT Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
TWST TTM Op. Margin: -31.9%
RAPT TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on TWST vs RAPT. Trailing 12-month operating profitability (TWST -31.9% vs RAPT 0.0%) and valuation multiples (TWST N/M vs RAPT N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | TWST | RAPT | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $7.6B | $1.7B | Larger Scale | TWST |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +23.2% | -100.0% | Higher Growth | TWST |
| Operating Margin (TTM) Profitability | -31.9% | 0.0% | Higher Margin | RAPT |
| Net Profit Margin Profitability | -31.7% | 0.0% | Higher Margin | RAPT |
| Return on Equity (ROE) Capital Efficiency | -29.6% | -85.4% | Higher ROE | TWST |
| 52-Week Range Position Momentum | 42% ($23โ$220) | 100% ($1โ$58) | Stronger Trend | RAPT |
| Beta / 30D Volatility Risk Regime | 3.13ฮฒ ยท 126% Vol | -0.02ฮฒ ยท 2% Vol | Lower Realized Risk | RAPT |
| Unified Institutional Score Composite Signal | 51.7 / 100 (HOLD) | 52.4 / 100 (HOLD) | Higher Composite | RAPT |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full TWST vs RAPT Buy Guide
TWST
CONSOLIDATION
69d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
18th %ile
IV Regime
Compressed (<25th %ile)
RAPT
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
<1st %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither TWST nor RAPT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.